Evidence map›Paper›PMID 41800383›Full record

ArticleBioinformatics advances2026

Sigscores: summary scores for molecular signatures in R.

Alessandro Barberis, Francesca M Buffa

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alessandro BarberisComputational Biology and Integrative Genomics Lab, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, United Kingdom.ORCID https://orcid.org/0000-0002-6718-855X
Francesca M BuffaComputational Biology and Integrative Genomics Lab, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, United Kingdom.ORCID https://orcid.org/0000-0003-0409-406X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: The rapid expansion of multi-omics data has enabled the development of molecular signatures-coordinated patterns of molecular features that serve as powerful biomarkers for diagnosis, prognosis, and therapeutic decision-making. Despite their potential, many published signatures suffer from limited reproducibility and narrow applicability, partly due to challenges in summarizing complex, multi-feature profiles into a single, statistically sound and biologically meaningful score. Here, we introduce sigscores, an R package that streamlines the computation of summary scores for molecular signatures. Building on the quality control principles of our earlier tool, sigQC, sigscores supports an extensive array of scoring metrics-including measures of central tendency, dispersion, and aggregation. It incorporates a resampling framework to generate empirical null distributions for rigorous significance assessment and provides integrated visualization tools for diagnostic evaluation. Optimized for parallel execution on multi-core systems, sigscores is well-suited for both exploratory research and high-throughput large-scale applications. Availability and implementation: Source code freely available for download on GitHub at https://github.com/alebarberis/sigscores, implemented in R and supported on MacOS and MS Windows.

Identifiers

PMID41800383
PMCPMC12967214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.